Skip to main content
Clinical Trials/PACTR202309805784870
PACTR202309805784870
Completed
未知

Pain Management in Post-Caesarean Sections: Nefopam vs. Pethidine

Self0 sites144 target enrollmentSeptember 4, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Post Cesearean setion pain
Sponsor
Self
Enrollment
144
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Self

Eligibility Criteria

Inclusion Criteria

  • ? All ASA II and III patients at term gestation for elective Caesarean section under subarachnoid block. ASA II and III are contradictions to what are labelled as exclusion criteria (PUD, DM and uncontrolled hypertension) .

Exclusion Criteria

  • ? Patient’s refusal to give written informed consent.
  • ? Patients with known allergy or sensitivity to the study medication
  • ? Present or past history of peptic ulcer disease
  • ? Contraindications to spinal anaesthesia
  • ? Diabetes mellitus Type 1 or 2
  • ? Systemic infection,
  • ?Patients with coexisting hepatic, renal, or cardiovascular disease.
  • ?History of chronic pain.
  • ?Opioid use 48hours preceding surgery.
  • ?Antenatal diagnosis of foetal abnormality

Outcomes

Primary Outcomes

Not specified

Similar Trials